消除麻疹背景下婴儿麻疹母体抗体衰减的系统文献综述
该系统综述检索多个数据库,纳入8项在已消除麻疹至少3年的国家开展的研究,评估未接种疫苗足月婴儿的麻疹母体抗体。两项研究报告出生时80%和100%婴儿有保护,一项报告3-7月龄婴儿无保护,另一项报告4月龄以上婴儿保护有限,提示部分婴儿在常规麻疹免疫接种年龄前已易感,需进一步开展血清阳性率和疫苗效果研究。
要点
- 在已消除麻疹至少3年的国家,部分婴儿在常规麻疹免疫接种年龄前已对麻疹易感。
- 两项研究报告出生时80%和100%婴儿有麻疹保护;一项报告3-7月龄婴儿无保护。
- 另一项研究报告4月龄以上婴儿保护有限;其余研究仅报告抗体检出比例而非免疫比例。
核心结论
- 尽管数据有限,这些数据提示在已持续消除麻疹的环境中,部分婴儿在常规麻疹免疫接种年龄之前就已对麻疹易感。
- 需要在不同辖区开展针对性的血清阳性率和疫苗效果研究来评估此问题。
研究设计与样本
- 系统文献综述,检索MEDLINE、Embase、CINAHL、Scopus、BIOSIS Previews和Global Health数据库。
- 纳入标准为研究所在国家已消除麻疹至少3年,队列包括健康、足月、未接种疫苗的12月龄及以下婴儿,其母亲健康,并报告婴儿麻疹母体抗体的相关指标。
- 采用MetaQAT工具评估研究质量。
- 共识别4692条唯一引文,其中8项研究符合纳入标准。
主要发现
- 一项研究报告脐带血中的抗麻疹抗体,六项报告婴儿血清中的抗体,一项同时报告两者。
- 两项研究报告出生时分别有80%和100%的婴儿对麻疹有保护。
- 一项研究报告3-7月龄婴儿中无保护。
- 另一项研究报告4月龄以上婴儿保护有限。
- 其余研究报告了检出抗体的婴儿比例,但未报告免疫比例。
临床怎么用
- 作者建议在不同辖区开展针对性的血清阳性率和疫苗效果研究以评估婴儿在常规麻疹免疫接种年龄前易感的问题。
局限性
- 数据有限。
- 需要在不同辖区进一步开展血清阳性率和疫苗效果研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Most infants are born with immunity to measles through maternal antibodies transferred in pregnancy, which decay over time. However, in measles elimination settings, where measles does not circulate endemically and most immunity is from immunization rather than infection, maternal antibody levels are lower. This results in infant immunity that wanes earlier, and a wider susceptibility gap between maternal antibody decay and infant immunization than in non-eliminated settings. We aimed to systematically quantify the extent and duration of protection from measles in infants in settings that have sustained measles elimination. METHODS: We conducted a systematic review of studies of measles maternal antibody waning in infants in measles elimination settings. We searched MEDLINE, Embase, CINAHL, Scopus, BIOSIS Previews, and Global Health databases for relevant studies. Studies were included if they were set in countries that had eliminated measles for ≥3 years, and if the study cohort included healthy, full-term, unvaccinated infants ≤12 months, born to healthy mothers, and reported a relevant measure of measles maternal antibody in infants. We assessed study quality using the MetaQAT tool. RESULTS: We identified 4692 unique citations, eight of which met inclusion criteria. One study reported anti-measles antibody in cord blood, six reported antibody in infant sera, and one reported both. Two studies reported that 80 and 100% of infants were protected from measles at birth. One study reported no protection amongst 3-7 month old infants, and another reported limited protection in infants >4 months. The remaining studies reported the proportion of infants with detected antibody, but not the proportion immune. CONCLUSION: Although limited, these data suggest that in settings that have sustained measles elimination, some infants are susceptible to measles well before the age of routine measles immunization. Setting-specific seroprevalence and vaccine effectiveness studies are required to evaluate this in different jurisdictions.
引用
- Guerra FM, Crowcroft NS, Friedman L, et al. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review. Vaccine. 2018. PMID: 29398276. doi:10.1016/j.vaccine.2018.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。